Authors


Nichole Tucker

Latest:

Web-based tool for family cancer history information collection

In an interview with Targeted Oncology, Melissa K. Frey, MD, discussed findings from implementing web-based health information collection of family history in patients with gynecologic cancers.


Kelly N. Wright, MD

Latest:

Surgical treatments for endometriosis

Laparoscopy remains the gold standard for diagnosis and treatment of the disease.


Staff

Latest:

IVIG safe, effective for treating pregnant patients with severe COVID-19

Intravenous immunoglobulin shows promise as a treatment option for pregnant patients with SARS-CoV-2, influenza, and other respiratory viruses.


Leen Al-Hafez, MD

Latest:

Deep dive into fetal ventriculomegaly

Fetal ventriculomegaly, a condition marked by the dilation of cerebral ventricles, is a common finding on second-trimester ultrasounds and requires careful evaluation to determine its causes, severity, and potential impact on neurological outcomes.


Kristl Tomlin, MD, FACOG

Latest:

A noninfectious “infection” after cesarean delivery

Experts evaluate 3 clinical scenarios and determine the appropriate course of action.


Danielle M. Alm, PharmD, BCPS, BCPPS

Latest:

Finding the best fit

Best practices on discussing birth control for adolescents.


Austin Cox, MD

Latest:

A noninfectious “infection” after cesarean delivery

Experts evaluate 3 clinical scenarios and determine the appropriate course of action.


Brian K. Iriye, MD

Latest:

Guiding ob-gyns back to evidence-based care

A thoughtful approach to behavioral change.


William Hynes, DPhil

Latest:

Violence against women and acquired brain injuries

Violence against women and resulting traumatic brain injuries increased during the COVID-19 pandemic.


Contemporary OB/GYN Staff

Latest:

Tiny Tim: What the diagnosis?

Can you guess what condition Tiny Tim had?


Howard Curlin, MD

Latest:

Endometrial ablation in the office setting

Breaking down barriers through patient selection, new devices, and the latest techniques.


Freya Shepherd, MSc, BSc

Latest:

An update on the presentation, nosology, and causes of postpartum psychosis

Postpartum psychosis is experienced by 1 to 2 women every 1000 deliveries.


Malavika Prabhu, MD

Latest:

SMFM Consult Series #57: Evaluation and management of soft ultrasound markers for aneuploidy

In this consult series, experts from SMFM discuss the evaluation and management of soft ultrasound markers for aneuploidy.


Kartik K. Venkatesh, MD, PHD

Latest:

Diagnosis and Management of Gestational Diabetes

What every OB/GYN needs to know to manage this complication.


Jeffrey Bendix

Latest:

COVID-19's impact on patient portal utilization and disparities

A recent study analyzing patient portal use amidst the COVID-19 pandemic unveils changes in sociodemographic trends and disparities, highlighting shifts in user behavior and access challenges.


Kristi Rosa

Latest:

FDA approves dostarlimab for dMMR endometrial cancer

The FDA has granted a regular approval to dostarlimab-gxly (Jemperli; GSK) for adult patients with mismatch repair–deficient, recurrent or advanced endometrial cancer that has progressed on or after a prior platinum-containing regimen in any setting and who are not candidates for curative surgery or radiation.


Joseph Biggio, MD, MS

Latest:

SMFM Consult Series #57: Evaluation and management of soft ultrasound markers for aneuploidy

In this consult series, experts from SMFM discuss the evaluation and management of soft ultrasound markers for aneuploidy.


Holly A. Rankin, MD

Latest:

Combined hormonal contraceptives merit risk assessment in patients with obesity

Combined hormonal contraceptives such as the combined oral contraceptive pill, the patch, and the vaginal ring each have unique considerations for use in patients with obesity.


Courtney Marabella

Latest:

Niraparib Demonstrates PFS Benefit in Chinese Population With Advanced Ovarian Cancer

First-line maintenance treatment with the PARP inhibitor niraparib yielded a clinically meaningful and statistically significant improvement in progression-free survival vs placebo in Chinese patients with platinum-responsive advanced ovarian cancer, regardless of biomarker status, according to data from the phase 3 PRIME trial.


Tiffany Avery, MD

Latest:

Treatment validation platforms can reduce care variations and promote health equity

Emerging technology helps ensure best practices while reducing costs of care.


S. Diane Yamada, MD

Latest:

Clues to the origins of ovarian cancer

Family history assessment, genetic screening are key to prevention.


Ceylan Colak, MD
Ceylan Colak, MD

Latest:

Megan Wasson, DO, and Ceylan Colak, MD, share how multidisciplinary collaboration advances endometriosis diagnosis and treatment

Megan Wasson, DO, and Ceylan Colak, MD, highlight how imaging and multidisciplinary care improve endometriosis diagnosis, treatment, and patient outcomes at the 2025 ACOG ACSM.


Deborah A. Koehn, MD

Latest:

Statin use in midlife women

Risk assessment, lifestyle counseling, adverse effects, and medication management.


Michael S. Jellinek, MD

Latest:

Helping parents cope with adolescent behavior

A teenager’s day-to-day behavior can vary greatly. Here are some tips for understanding and navigating this challenging time.


Anne-Marie Amies Oelschlager, MD

Latest:

Uterine anomalies in pregnancy

Clinical pearls for assessment and management of the pregnant patient with a uterovaginal anomaly.


Mike Hennessy Jr, President & CEO

Latest:

Bladder health month

Review bladder disorders and management methods you can discuss with your patients.


Caitlin Delaney, MD

Latest:

Addressing burnout before impacting your family

Today is Physician Family Day, the perfect time to reflect and address any potential burnout symptoms and spend quality time re-engaging with your loved ones.


David Kimball, MD

Latest:

Demystifying AVMs

Risk assessment and management of brain arteriovenous malformations in pregnancy.


Aislinn Antrim

Latest:

Pembrolizumab plus lenvatinib show promise in advanced endometrial carcinoma

New trial results showed statistically significant improvements in overall survival and progression-free survival.


Joe Nadglowski

Latest:

COVID-19 delays cancer screenings, deaths expected to rise in next 10 years

Cancer programs seek to remove barriers to screenings.

© 2025 MJH Life Sciences

All rights reserved.